No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.3x · 10Y median 1.3x · 8th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 37
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2025-05-08.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:01:17.527Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Krispy Kreme, Inc. (DNUT) stock was $2.93 as of Oct 6, 2026, 10:00 AM EDT, up 1.38% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -23.4% · 3-year avg -38.0%/yr · 5-year avg -26.3%/yr
Krispy Kreme, Inc., operating alongside its various subsidiaries, focuses on creating and distributing distinctive doughnut experiences through a comprehensive omni-channel business model. Its operations are structured across three primary divisions: U.S.
Grocery Stores · Charlotte, NC
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.02
Revenue Est.
$305.67M
Last Quarter Results
EPS
$-0.03
vs Estimate
$-0.02
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1DNUT | $505.13M | $2.93 | +1.38% | -23.45% | -26.27% | N/A | N/A |
| 2HNST | $565.19M | $5.13 | -0.30% | +40.10% | -11.82% | N/A | vs DNUT |
| 3HELE | $595.11M | $25.55 | -0.35% | -3.01% | -34.93% | -11.45% | vs DNUT |
| 4MAMA | $595.96M | $12.82 | -0.02% | +20.38% | +41.01% | N/A | vs DNUT |
| 5AGCC | $326.99M | $14.35 | -4.33% | N/A | N/A | N/A | vs DNUT |
| 6LWAY | $320.69M | $20.98 | -0.07% | -17.41% | +30.78% | +3.30% | vs DNUT |
forward FY estimate
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$331.00M
vs Estimate
$303.35M
Consensus Rating
Based on 6 analysts
Average Price Target
$4.08
+39.4% upside
Low
$3.00
Current
$2.93
High
$5.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.01 | $0.01 | $0.02 | 3 |
| Quarter ending Dec 2026 | $0.05 | $0.06 | $0.06 | 3 |
| Quarter ending Mar 2027 | $0.00 | $0.00 | $0.00 | 1 |
| Quarter ending Jun 2027 | $0.00 | $0.00 | $0.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.02 | $-0.01 | $0.01 | 3 |
| FY 2027 | $0.05 | $0.08 | $0.10 | 4 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $291.66M | $305.67M | $316.06M | 3 |
| Quarter ending Dec 2026 | $327.22M | $340.13M | $351.26M | 3 |
| Quarter ending Mar 2027 | $323.48M | $336.27M | $349.83M | 2 |
| Quarter ending Jun 2027 | $325.72M | $338.60M | $352.25M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.30B | $1.33B | $1.34B | 5 |
| FY 2027 | $1.24B | $1.34B | $1.50B | 5 |
